Tumor suppressor microRNAs contribute to the regulation of PD-L1 expression in malignant pleural mesothelioma (vol 12, pg 1421, 2017)

被引：0
|
作者：
Kao, S. C.
Cheng, Y. Y.
Williams, M.
机构：
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：587 / 587
页数：1
相关论文
共 50 条
  • [21] Nuclear grading, BAP1, mesothelin and PD-L1 expression in malignant pleural mesothelioma: prognostic implications
    Forest, Fabien
    Patoir, Arnaud
    Dal Col, Pierre
    Sulaiman, Abdulrazzaq
    Camy, Florian
    Laville, David
    Bayle-Bleuez, Sophie
    Fournel, Pierre
    Habougit, Cyril
    PATHOLOGY, 2018, 50 (06) : 635 - 641
  • [22] Regulation of PD-L1 expression in the tumor microenvironment
    Yi, Ming
    Niu, Mengke
    Xu, Linping
    Luo, Suxia
    Wu, Kongming
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
  • [23] Regulation of PD-L1 expression in the tumor microenvironment
    Ming Yi
    Mengke Niu
    Linping Xu
    Suxia Luo
    Kongming Wu
    Journal of Hematology & Oncology, 14
  • [24] Expression of PD-L1 in Patients With Malignant Peritoneal Mesothelioma: A Pilot Study
    Gazivoda, Victor P.
    Kangas-Dick, Aaron W.
    Greenbaum, Alissa A.
    Roshal, Joshua
    Chen, Chunxia
    Moore, Dirk F.
    Langan, Russell C.
    Kennedy, Timothy J.
    Minerowicz, Christine
    Alexander, H. Richard
    JOURNAL OF SURGICAL RESEARCH, 2022, 277 : 131 - 137
  • [25] PD-L1 Expression in Malignant Mesothelioma: An Imunohistochemical Analysis of 33 Cases
    Cowan, M. L.
    Forde, P. M.
    Taube, J. M.
    Brahmer, J.
    Illei, P. B.
    MODERN PATHOLOGY, 2014, 27 : 476A - 476A
  • [26] PD-L1 Expression in Malignant Mesothelioma: An Immunohistochemical Analysis of 33 Cases
    Cowan, M. L.
    Forde, P. M.
    Taube, J. M.
    Brahmer, J.
    Illei, P. B.
    LABORATORY INVESTIGATION, 2014, 94 : 476A - 476A
  • [27] Trametinib plus 4-Methylumbelliferone Exhibits Antitumor Effects by ERK Blockade and CD44 Downregulation and Affects PD-1 and PD-L1 in Malignant Pleural Mesothelioma.(Vol 12, pg 477, 2017)
    Cho, H.
    Matsumoto, S.
    Fujita, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (05) : 900 - 900
  • [28] Histologic features, nuclear grading, BAP1 and PD-L1 expression in malignant pleural mesothelioma: analysis of a monoinstitutional series
    Terzioglu, H. G.
    Onder, S.
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S26 - S26
  • [29] Malignant pleural mesothelioma: clinical experience and prognostic value of derived neutrophil-to-lymphocyte ratio and PD-L1 expression
    L. Gutierrez-Sainz
    P. Cruz
    S. Martinez-Recio
    O. Higuera
    M. I. Esteban-Rodriguez
    F. Arias-Lotto
    R. A. Gonzalez
    J. De Castro-Carpeño
    Clinical and Translational Oncology, 2021, 23 : 2030 - 2035
  • [30] Malignant pleural mesothelioma: clinical experience and prognostic value of derived neutrophil-to-lymphocyte ratio and PD-L1 expression
    Gutierrez-Sainz, L.
    Cruz, P.
    Martinez-Recio, S.
    Higuera, O.
    Esteban-Rodriguez, M., I
    Arias-Lotto, F.
    Gonzalez, R. A.
    De Castro-Carpeno, J.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2021, 23 (10): : 2030 - 2035
12345